GENEWIZ Executive and Leadership Team

Anifa Kabale, the Chief Executive Officer at GENEWIZ, directs the company's overarching strategy and operational execution. Overseeing all facets of the R&D genomics services business, Kabale ensures the delivery of Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services. This leadership role involves guiding the company's market positioning and fostering innovation within the scientific community. By aligning departmental objectives with corporate goals, Anifa Kabale drives the expansion of service offerings and enhances client engagement. The Chief Executive Officer's focus remains on advancing the company's mission to accelerate research through cutting-edge genomics solutions, solidifying GENEWIZ's position as a leader in the field.

Lawrence Lin, the Executive Vice President & Chief Financial Officer at GENEWIZ, manages the company's financial health and strategic fiscal planning. Overseeing all financial operations, Lin ensures robust management of resources supporting the R&D genomics services, including Sanger DNA sequencing, gene synthesis, and high throughput/next-generation sequencing. This executive position involves close collaboration with other leaders to align financial strategies with business objectives, driving sustainable growth and operational efficiency. By optimizing capital allocation and managing financial risks, Lawrence Lin supports the company's expansion into new markets and service areas. The Executive Vice President & Chief Financial Officer's responsibilities extend to financial reporting, budgeting, and investor relations, ensuring transparency and fiscal integrity across the organization.

Susheelan Variyathe, the Chief Financial Officer, Sample Management Solutions at GENEWIZ, spearheads financial strategy specifically for the sample management division. Overseeing the financial performance and resource allocation for this critical segment, Variyathe ensures profitability and efficient operations supporting specialized genomics services. This role involves close coordination with operations and R&D teams to manage budgets, forecast financial needs, and identify cost-saving opportunities within sample management processes. By implementing rigorous financial controls and reporting mechanisms, Susheelan Variyathe contributes to the overall financial stability and strategic direction of GENEWIZ. The Chief Financial Officer, Sample Management Solutions' focus is on maximizing the value and efficiency of sample handling services, directly impacting client satisfaction and the company's competitive edge.

James Dorey, the Divisional Chief Financial Officer, Genewiz at GENEWIZ, directs financial operations across the core genomics services business units. Overseeing the financial health of divisions providing Sanger DNA sequencing, gene synthesis, and molecular biology services, Dorey ensures fiscal discipline and strategic resource deployment. This leadership position involves developing and executing financial plans that support innovation and market expansion, working closely with operational leaders to optimize performance. By managing budgets, analyzing financial data, and mitigating fiscal risks, James Dorey strengthens the company's financial foundation. The Divisional Chief Financial Officer, Genewiz's mandate includes driving revenue growth and enhancing profitability through effective financial management and strategic insights, reinforcing GENEWIZ's commitment to scientific advancement.